Cina has grabbed 90 percent of the U.S. market for vitamin C in a year moving almost every enterprise out of business, as per the news published on Kentucky.com.
Chinese pharmaceutical firms have dominance over major part of global market in analgesics, antibiotics, primary amino-acids and enzymes' production. As per an industry group, the country produces 50 percent of worldwide aspirin, 70% of penicillin, and 35% of acetaminophen (sold under brandname Tylenol), and the volume of vitamins B12, A, C and E.
China's pharmaceutical market is increasing at a yearly rate above fifteen percent with the ethical drug market valued above $6 billion. China's over-the-counter drug market is presently priced at more than $1.2 billion and is projected to attain $5 billion by 2010.
China's GDP is growing and people's life standard is increasing thereby, positively impacting the medicine intake of population. The Chinese government, recognizing growth, has also certified improved subsidy for better disease prevention. Presently, prescription drugs possess slightly less than 80% of total market, though over-the-counter (OTC) products are gradually making their way. At two-thirds of market by value, generics will persist to dominate branded sector, even though the lax intellectual property (IP) rule will carry on to encourage the invention and use of unlawful copy drugs.
The Chinese government has an active role in pharmaceutical development of country. The prologue of WTO guidelines and protection for intellectual property privileges has initiated a rework in company arrangement of China, making some to shut business or venture into new associations.
China's continuing industrial expansion, improving political ingenuousness and constructive infrastructure amendment will provide the success in future. The tricky IP and pricing environment may, on the other hand, delay pharmaceutical sector enlargement in coming years.
As per a research analyst at RNCOS, "Recognizing the potential, the government is escalating investment in research institutes and pharmaceutical companies as well to persuade innovation. The Chinese pharmaceutical market is undergoing reorganization to divide the function of administration and enterprise, and is expecting an enormous expansion in the foreseeable future".
Related Market Research Reports:
China Healthcare Sector Analysis
Global In Vitro Diagnostic Market Analysis
Insulin Delivery Systems Market Analysis (2007-2010)
